Shop
Description
Synjardy Tab 5/1000 contains a combination of empagliflozin and metformin, used primarily to treat type 2 diabetes mellitus.
Drug Class:
– Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor.
– Metformin is a biguanide antihyperglycemic agent.
Mechanism of Action:
Empagliflozin works by blocking glucose reabsorption in the kidneys, promoting the elimination of excess glucose through urine, which helps lower blood sugar levels. Metformin decreases glucose production in the liver and improves insulin sensitivity, aiding blood sugar control.
Primary Uses:
– Management of type 2 diabetes to improve blood sugar control.
– Often prescribed when metformin alone is insufficient to control blood glucose levels.
Forms:
– Oral tablet.
Dosage Instructions:
– The dosage is determined by a healthcare provider based on the patient’s condition and response.
– Typically taken once or twice daily with meals to reduce gastrointestinal side effects.
Common Side Effects:
– Urinary tract infections.
– Increased urination.
– Gastrointestinal symptoms like nausea, diarrhea, or stomach upset.
– Possible risk of lactic acidosis (rare but serious), especially with metformin.
Contraindications and Precautions:
– Not recommended for patients with severe kidney impairment or diabetic ketoacidosis.
– Use caution in patients with a history of urinary tract infections or dehydration.
– Regular monitoring of kidney function and blood sugar levels is advised during treatment.
Synjardy combines the benefits of empagliflozin and metformin to provide effective blood sugar management in type 2 diabetes under medical supervision.
Reviews
There are no reviews yet.